Cargando…

Risk of hospital admission and death from first-ever SARS-CoV-2 infection by age group during the Delta and Omicron periods in British Columbia, Canada

BACKGROUND: Population-based cross-sectional serosurveys within the Lower Mainland, British Columbia, Canada, showed about 10%, 40% and 60% of residents were infected with SARS-CoV-2 by the sixth (September 2021), seventh (March 2022) and eighth (July 2022) serosurveys. We conducted the ninth (Decem...

Descripción completa

Detalles Bibliográficos
Autores principales: Skowronski, Danuta M., Kaweski, Samantha E., Irvine, Michael A., Chuang, Erica S.Y., Kim, Shinhye, Sabaiduc, Suzana, Reyes, Romina C., Henry, Bonnie, Sekirov, Inna, Smolina, Kate
Formato: Online Artículo Texto
Lenguaje:English
Publicado: CMA Impact Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10615343/
https://www.ncbi.nlm.nih.gov/pubmed/37903524
http://dx.doi.org/10.1503/cmaj.230721
_version_ 1785129202942476288
author Skowronski, Danuta M.
Kaweski, Samantha E.
Irvine, Michael A.
Chuang, Erica S.Y.
Kim, Shinhye
Sabaiduc, Suzana
Reyes, Romina C.
Henry, Bonnie
Sekirov, Inna
Smolina, Kate
author_facet Skowronski, Danuta M.
Kaweski, Samantha E.
Irvine, Michael A.
Chuang, Erica S.Y.
Kim, Shinhye
Sabaiduc, Suzana
Reyes, Romina C.
Henry, Bonnie
Sekirov, Inna
Smolina, Kate
author_sort Skowronski, Danuta M.
collection PubMed
description BACKGROUND: Population-based cross-sectional serosurveys within the Lower Mainland, British Columbia, Canada, showed about 10%, 40% and 60% of residents were infected with SARS-CoV-2 by the sixth (September 2021), seventh (March 2022) and eighth (July 2022) serosurveys. We conducted the ninth (December 2022) and tenth (July 2023) serosurveys and sought to assess risk of severe outcomes from a first-ever SARS-CoV-2 infection during intersurvey periods. METHODS: Using increments in cumulative infection-induced seroprevalence, population census, discharge abstract and vital statistics data sets, we estimated infection hospitalization and fatality ratios (IHRs and IFRs) by age and sex for the sixth to seventh (Delta/Omicron-BA.1), seventh to eighth (Omicron-BA.2/BA.5) and eighth to ninth (Omicron-BA.5/BQ.1) intersurvey periods. As derived, IHR and IFR estimates represent the risk of severe outcome from a first-ever SARS-CoV-2 infection acquired during the specified intersurvey period. RESULTS: The cumulative infection-induced seroprevalence was 74% by December 2022 and 79% by July 2023, exceeding 80% among adults younger than 50 years but remaining less than 60% among those aged 80 years and older. Period-specific IHR and IFR estimates were consistently less than 0.3% and 0.1% overall. By age group, IHR and IFR estimates were less than 1.0% and up to 0.1%, respectively, except among adults aged 70–79 years during the sixth to seventh intersurvey period (IHR 3.3% and IFR 1.0%) and among those aged 80 years and older during all periods (IHR 4.7%, 2.2% and 3.5%; IFR 3.3%, 0.6% and 1.3% during the sixth to seventh, seventh to eighth and eighth to ninth periods, respectively). The risk of severe outcome followed a J-shaped age pattern. During the eighth to ninth period, we estimated about 1 hospital admission for COVID-19 per 300 newly infected children younger than 5 years versus about 1 per 30 newly infected adults aged 80 years and older, with no deaths from COVID-19 among children but about 1 death per 80 newly infected adults aged 80 years and older during that period. INTERPRETATION: By July 2023, we estimated about 80% of residents in the Lower Mainland, BC, had been infected with SARS-CoV-2 overall, with low risk of hospital admission or death; about 40% of the oldest adults, however, remained uninfected and at highest risk of a severe outcome. First infections among older adults may still contribute substantial burden from COVID-19, reinforcing the need to continue to prioritize this age group for vaccination and to consider them in health care system planning.
format Online
Article
Text
id pubmed-10615343
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher CMA Impact Inc.
record_format MEDLINE/PubMed
spelling pubmed-106153432023-10-31 Risk of hospital admission and death from first-ever SARS-CoV-2 infection by age group during the Delta and Omicron periods in British Columbia, Canada Skowronski, Danuta M. Kaweski, Samantha E. Irvine, Michael A. Chuang, Erica S.Y. Kim, Shinhye Sabaiduc, Suzana Reyes, Romina C. Henry, Bonnie Sekirov, Inna Smolina, Kate CMAJ Research BACKGROUND: Population-based cross-sectional serosurveys within the Lower Mainland, British Columbia, Canada, showed about 10%, 40% and 60% of residents were infected with SARS-CoV-2 by the sixth (September 2021), seventh (March 2022) and eighth (July 2022) serosurveys. We conducted the ninth (December 2022) and tenth (July 2023) serosurveys and sought to assess risk of severe outcomes from a first-ever SARS-CoV-2 infection during intersurvey periods. METHODS: Using increments in cumulative infection-induced seroprevalence, population census, discharge abstract and vital statistics data sets, we estimated infection hospitalization and fatality ratios (IHRs and IFRs) by age and sex for the sixth to seventh (Delta/Omicron-BA.1), seventh to eighth (Omicron-BA.2/BA.5) and eighth to ninth (Omicron-BA.5/BQ.1) intersurvey periods. As derived, IHR and IFR estimates represent the risk of severe outcome from a first-ever SARS-CoV-2 infection acquired during the specified intersurvey period. RESULTS: The cumulative infection-induced seroprevalence was 74% by December 2022 and 79% by July 2023, exceeding 80% among adults younger than 50 years but remaining less than 60% among those aged 80 years and older. Period-specific IHR and IFR estimates were consistently less than 0.3% and 0.1% overall. By age group, IHR and IFR estimates were less than 1.0% and up to 0.1%, respectively, except among adults aged 70–79 years during the sixth to seventh intersurvey period (IHR 3.3% and IFR 1.0%) and among those aged 80 years and older during all periods (IHR 4.7%, 2.2% and 3.5%; IFR 3.3%, 0.6% and 1.3% during the sixth to seventh, seventh to eighth and eighth to ninth periods, respectively). The risk of severe outcome followed a J-shaped age pattern. During the eighth to ninth period, we estimated about 1 hospital admission for COVID-19 per 300 newly infected children younger than 5 years versus about 1 per 30 newly infected adults aged 80 years and older, with no deaths from COVID-19 among children but about 1 death per 80 newly infected adults aged 80 years and older during that period. INTERPRETATION: By July 2023, we estimated about 80% of residents in the Lower Mainland, BC, had been infected with SARS-CoV-2 overall, with low risk of hospital admission or death; about 40% of the oldest adults, however, remained uninfected and at highest risk of a severe outcome. First infections among older adults may still contribute substantial burden from COVID-19, reinforcing the need to continue to prioritize this age group for vaccination and to consider them in health care system planning. CMA Impact Inc. 2023-10-30 2023-10-23 /pmc/articles/PMC10615343/ /pubmed/37903524 http://dx.doi.org/10.1503/cmaj.230721 Text en © 2023 CMA Impact Inc. or its licensors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY-NC-ND 4.0) licence, which permits use, distribution and reproduction in any medium, provided that the original publication is properly cited, the use is noncommercial (i.e., research or educational use), and no modifications or adaptations are made. See: https://creativecommons.org/licenses/by-nc-nd/4.0/
spellingShingle Research
Skowronski, Danuta M.
Kaweski, Samantha E.
Irvine, Michael A.
Chuang, Erica S.Y.
Kim, Shinhye
Sabaiduc, Suzana
Reyes, Romina C.
Henry, Bonnie
Sekirov, Inna
Smolina, Kate
Risk of hospital admission and death from first-ever SARS-CoV-2 infection by age group during the Delta and Omicron periods in British Columbia, Canada
title Risk of hospital admission and death from first-ever SARS-CoV-2 infection by age group during the Delta and Omicron periods in British Columbia, Canada
title_full Risk of hospital admission and death from first-ever SARS-CoV-2 infection by age group during the Delta and Omicron periods in British Columbia, Canada
title_fullStr Risk of hospital admission and death from first-ever SARS-CoV-2 infection by age group during the Delta and Omicron periods in British Columbia, Canada
title_full_unstemmed Risk of hospital admission and death from first-ever SARS-CoV-2 infection by age group during the Delta and Omicron periods in British Columbia, Canada
title_short Risk of hospital admission and death from first-ever SARS-CoV-2 infection by age group during the Delta and Omicron periods in British Columbia, Canada
title_sort risk of hospital admission and death from first-ever sars-cov-2 infection by age group during the delta and omicron periods in british columbia, canada
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10615343/
https://www.ncbi.nlm.nih.gov/pubmed/37903524
http://dx.doi.org/10.1503/cmaj.230721
work_keys_str_mv AT skowronskidanutam riskofhospitaladmissionanddeathfromfirsteversarscov2infectionbyagegroupduringthedeltaandomicronperiodsinbritishcolumbiacanada
AT kaweskisamanthae riskofhospitaladmissionanddeathfromfirsteversarscov2infectionbyagegroupduringthedeltaandomicronperiodsinbritishcolumbiacanada
AT irvinemichaela riskofhospitaladmissionanddeathfromfirsteversarscov2infectionbyagegroupduringthedeltaandomicronperiodsinbritishcolumbiacanada
AT chuangericasy riskofhospitaladmissionanddeathfromfirsteversarscov2infectionbyagegroupduringthedeltaandomicronperiodsinbritishcolumbiacanada
AT kimshinhye riskofhospitaladmissionanddeathfromfirsteversarscov2infectionbyagegroupduringthedeltaandomicronperiodsinbritishcolumbiacanada
AT sabaiducsuzana riskofhospitaladmissionanddeathfromfirsteversarscov2infectionbyagegroupduringthedeltaandomicronperiodsinbritishcolumbiacanada
AT reyesrominac riskofhospitaladmissionanddeathfromfirsteversarscov2infectionbyagegroupduringthedeltaandomicronperiodsinbritishcolumbiacanada
AT henrybonnie riskofhospitaladmissionanddeathfromfirsteversarscov2infectionbyagegroupduringthedeltaandomicronperiodsinbritishcolumbiacanada
AT sekirovinna riskofhospitaladmissionanddeathfromfirsteversarscov2infectionbyagegroupduringthedeltaandomicronperiodsinbritishcolumbiacanada
AT smolinakate riskofhospitaladmissionanddeathfromfirsteversarscov2infectionbyagegroupduringthedeltaandomicronperiodsinbritishcolumbiacanada